I believe that CA...saw the writing on the wall...and felt the first loss is the best loss. Your comment on the continued viability of the BLA...is on target. We needed to shed HIV-MDR for the moment as a possible rehash when the til is fuller...which could ignite/suggest a reopening...
All the while... Dr. Sacha is working with that NIH 5 million dollar grant...and our product. All in All...a prudent move...and a narrower focus on larger TAMs.